To include your compound in the COVID-19 Resource Center, submit it here.

VAS972: Began Phase II testing

Vasogen Inc. (TSE:VAS; MEW), Toronto,

Read the full 52 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE